Phenanthriplatin
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Phenanthriplatin or cis-[Pt(NH 3 ) 2 -(phenanthridine)Cl]NO 3 is a new drug candidate. It belongs to a family of platinum(II)-based agents which includes cisplatin, oxaliplatin and carboplatin. Phenanthriplatin was discovered by Professor Stephen J. Lippard at Massachusetts Institute of Technology and is currently being developed by Blend Therapeutics for its potential use in human cancer therapy.
Phenanthriplatin or cis-[Pt(NH 3 ) 2 -(phenanthridine)Cl]NO 3 is a new drug candidate. It belongs to a family of platinum(II)-based agents which includes cisplatin, oxaliplatin and carboplatin. Phenanthriplatin was discovered by Professor Stephen J. Lippard at Massachusetts Institute of Technology and is currently being developed by Blend Therapeutics for its potential use in human cancer therapy.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1360203742 under CC BY-SA 4.0; modifications have been made.